日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Concordance analysis of DNA and RNA profiling: The MD Anderson IMPACT2 study in precision oncology

DNA和RNA谱分析的一致性分析:MD安德森癌症中心IMPACT2精准肿瘤学研究

Schmidt, Stephanie T; Baysal, Mehmet A; Fu, Siqing; Hong, David S; Piha-Paul, Sarina A; Naing, Aung; Rodon Ahnert, Jordi; Yap, Timothy A; Dumbrava, Ecaterina Elena; Beck, Jennifer; Meric-Bernstam, Funda; Tsimberidou, Apostolia Maria

Advances in Targeting HER2 across Cancer Subtypes: A Pan-Tumor Approach

针对HER2靶向治疗癌症亚型的进展:一种泛肿瘤方法

Adesoye, Taiwo; Dumbrava, Ecaterina E; Raghav, Kanwal P S; Sahin, Aysegul A; Chen, Hui; Lee, Sunyoung S; Javle, Milind M; Pant, Shubham; Alhalabi, Omar; Le, Xiuning; Valero, Vicente; Pohlmann, Paula R; Meric-Bernstam, Funda

Therapeutic responses in patients with advanced NSCLC enrolled in early-phase clinical trials at MD Anderson

在MD安德森癌症中心早期临床试验中入组的晚期非小细胞肺癌患者的治疗反应

Lim, Jeong Uk; Lin, Heather Y; Kang, Lei; Le, Hung; Tang, Tin-Yun; Champiat, Stephane; Dumbrava, Ecaterina Elena; Le, Xiuning; Naing, Aung; Piha-Paul, Sarina A; Ahnert, Jordi Rodon; Tsimberidou, Apostolia Maria; Yap, Timothy A; Fu, Siqing; Meric-Bernstam, Funda; Hong, David S

Single-cell resolution of an open chromatin signature in persister tumor cells

持续性肿瘤细胞中开放染色质特征的单细胞分辨率分析

Dumbrava, Mihai Gabriel; Mohammed Ismail, Wazim; Sandoval, Leticia; Mazzone, Amelia; Aalam, Syed Mohammed Musheer; Ritting, Megan L; Hou, Xiaonan; Xie, Yiwen; Hamernick, Sierra; Hu, Chunling; Couch, Fergus J; Harrington, Shariska P; Kaufmann, Scott H; Kannan, Nagarajan; Weroha, S John; Gaspar-Maia, Alexandre

Telemedicine as a gateway to early-phase oncology trials: lessons from 14 000 patients and future directions for global access and equity

远程医疗作为早期肿瘤临床试验的途径:来自14000名患者的经验教训以及全球可及性和公平性的未来方向

Torrado, Carlos; Andersen, Clark R; Kang, Lei; Brink, Amanda L; Adesoye, Taiwo; Le, Hung; Patterson, Clover J; Poullard, Anna; Osburn, Jessica A; Tan, Harold N; Gouda, Mohamed A; Charles, Sheena; Urschel, Gabriele E; Tang, Tin-Yun; Hong, David S; Champiat, Stephane; Naing, Aung; Tsimberidou, Apostolia M; Dumbrava, Ecaterina E; Piha-Paul, Sarina A; Rodon, Jordi; Yap, Timothy A; Pohlmann, Paula R; Meric-Bernstam, Funda; Fu, Siqing

MDX-2001-101 study protocol: a phase I/IIa, multicenter, first-in-human, open-label clinical trial evaluating MDX2001 monotherapy in patients with advanced solid tumors

MDX-2001-101 研究方案:一项 I/IIa 期、多中心、首次人体试验、开放标签临床试验,评估 MDX2001 单药治疗晚期实体瘤患者的疗效

Dumbrava, Ecaterina; Minchom, Anna; Henry, Jason; Johnson, Melissa; Sommerhalder, David; Merchan, Jaime; Heist, Rebecca; Cabanas, Elena Garralda; Cotreau, Monette; Goenaga, Anne-Laure; Burzyn, Dalia; Makris, Lukas; Culm, Kerry; Abbadessa, Giovanni

Beamion PANTUMOR-1: rationale and design of a Phase II trial of zongertinib in HER2-overexpressed/amplified or HER2-mutant solid tumors

Beamion PANTUMOR-1:zongertinib治疗HER2过表达/扩增或HER2突变实体瘤的II期试验的理论依据和设计

Schram, Alison M; Park, John J; Italiano, Antoine; Kitano, Shigehisa; Guo, Ye; Li, Jin; Bedard, Philippe L; van Marcke, Cedric; Ko, Ryo; Lunger, Lukas; Klotz, Daniel M; Hussain, Jo; Maier, Daniela; Erzen, Damijan; Planchard, David; Prenen, Hans; Clay, Timothy D; Park, Joon O; Kim, Hyung-Don; Hernando-Calvo, Alberto; Maruki, Yuta; Ponz-Sarvise, Mariano; Dumbrava, Ecaterina

Milademetan in Advanced Solid Tumors with MDM2 Amplification and Wild-type TP53: Preclinical and Phase II Clinical Trial Results

米拉德美坦治疗MDM2扩增和TP53野生型晚期实体瘤:临床前和II期临床试验结果

Dumbrava, Ecaterina E; Stinchcombe, Thomas E; Gounder, Mrinal; Cote, Gregory M; Hanna, Glenn J; Sumrall, Bradley; Wise-Draper, Trisha M; Kanaan, Mohammed; Duffy, Steven; Sumey, Christopher; Cobb, Patrick; Forbes, Andre; Beckmann, Aviva G; Schadt, Eric E; Ku, Nora; Tirunagaru, Vijaya G; Singh, Kanchan; Pei, Xinyu; Xu, Feng; Doebele, Robert C; Chen, Christopher T

Phase Ib Study of Pembrolizumab in Combination with Intratumoral Injection of Clostridium novyi-NT in Patients with Advanced Solid Tumors.

帕博利珠单抗联合瘤内注射诺维梭菌-NT治疗晚期实体瘤患者的Ib期研究。

Nelson Blessie Elizabeth, Janku Filip, Fu Siqing, Dumbrava Ecaterina E, Hong David S, Karp Daniel D, Naing Aung, Rodon Jordi, Tsimberidou Apostolia M, Murthy Ravi, Sheth Rahul A, Amaria Rodabe N, Conley Anthony P, Damodaran Senthil, Raghav Kanwal P S, Carapanceanu Nicoleta, Singh Mahendra Pal, Carapanceanu Valentin, Pezeshki Abdulmohammad, Leontovich Alexey A, Kreider Brent L, Tung David, Varterasian Mary, Khazaie Khashayarsha, Piha-Paul Sarina A

Phase I trial of the combination of the pan-ErbB inhibitor neratinib and mTOR inhibitor everolimus in advanced cancer patients with ErbB family gene alterations

泛ErbB抑制剂neratinib与mTOR抑制剂everolimus联合治疗ErbB家族基因改变的晚期癌症患者的I期临床试验

Piha-Paul, S A; Tseng, C; Tran, H T; Naing, A; Dumbrava, E E; Karp, D D; Rodon, J; Yap, T A; Raghav, K P; Damodaran, S; Le, X; Soliman, P T; Lim, J; Meric-Bernstam, F